366 related articles for article (PubMed ID: 22230329)
1. Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties.
Vendel MC; Favis M; Snyder WB; Huang F; Capili AD; Dong J; Glaser SM; Miller BR; Demarest SJ
Arch Biochem Biophys; 2012 Oct; 526(2):188-93. PubMed ID: 22230329
[TBL] [Abstract][Full Text] [Related]
2. Stability engineering of scFvs for the development of bispecific and multivalent antibodies.
Miller BR; Demarest SJ; Lugovskoy A; Huang F; Wu X; Snyder WB; Croner LJ; Wang N; Amatucci A; Michaelson JS; Glaser SM
Protein Eng Des Sel; 2010 Jul; 23(7):549-57. PubMed ID: 20457695
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic bispecific antibodies: The selection of stable single-chain fragments to overcome engineering obstacles.
Mabry R; Snavely M
IDrugs; 2010 Aug; 13(8):543-9. PubMed ID: 20721825
[TBL] [Abstract][Full Text] [Related]
4. Engineering of stable bispecific antibodies targeting IL-17A and IL-23.
Mabry R; Lewis KE; Moore M; McKernan PA; Bukowski TR; Bontadelli K; Brender T; Okada S; Lum K; West J; Kuijper JL; Ardourel D; Franke S; Lockwood L; Vu T; Frank A; Appleby MW; Wolf A; Reardon B; Hamacher NB; Stevens B; Lewis P; Lewis KB; Gilbertson DG; Lantry M; Julien SH; Ostrander C; Chan C; Byrnes-Blake K; Brody J; Presnell S; Meengs B; Levin SD; Snavely M
Protein Eng Des Sel; 2010 Mar; 23(3):115-27. PubMed ID: 20022918
[TBL] [Abstract][Full Text] [Related]
5. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
[TBL] [Abstract][Full Text] [Related]
6. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
[TBL] [Abstract][Full Text] [Related]
7. Nanocell targeting using engineered bispecific antibodies.
Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
[TBL] [Abstract][Full Text] [Related]
8. A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies.
Sun W; Xie J; Lin H; Mi S; Li Z; Hua F; Hu Z
Protein Expr Purif; 2012 May; 83(1):21-9. PubMed ID: 22387083
[TBL] [Abstract][Full Text] [Related]
9. Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm.
Vaks L; Benhar I
Methods Mol Biol; 2014; 1060():171-84. PubMed ID: 24037842
[TBL] [Abstract][Full Text] [Related]
10. Construction and production of an IgG-Like tetravalent bispecific antibody, IgG-single-chain Fv fusion.
Lu D; Zhu Z
Methods Mol Biol; 2014; 1060():185-213. PubMed ID: 24037843
[TBL] [Abstract][Full Text] [Related]
11. Redesigning of anti-c-Met single chain Fv antibody for the cytoplasmic folding and its structural analysis.
Edwardraja S; Neelamegam R; Ramadoss V; Venkatesan S; Lee SG
Biotechnol Bioeng; 2010 Jun; 106(3):367-75. PubMed ID: 20178123
[TBL] [Abstract][Full Text] [Related]
12. Characterization and analysis of scFv-IgG bispecific antibody size variants.
Cao M; Wang C; Chung WK; Motabar D; Wang J; Christian E; Lin S; Hunter A; Wang X; Liu D
MAbs; 2018; 10(8):1236-1247. PubMed ID: 30130449
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.
Jurado P; de Lorenzo V; Fernández LA
J Mol Biol; 2006 Mar; 357(1):49-61. PubMed ID: 16427080
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression and efficient refolding of carbohydrate-peptide mimicry recognizing single chain antibody 2D10.
Tapryal S; Krishnan L; Batra JK; Kaur KJ; Salunke DM
Protein Expr Purif; 2010 Aug; 72(2):162-8. PubMed ID: 20363331
[TBL] [Abstract][Full Text] [Related]
15. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
[TBL] [Abstract][Full Text] [Related]
16. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
[TBL] [Abstract][Full Text] [Related]
17. Construction of multiform scFv antibodies using linker peptide.
Wang S; Zheng C; Liu Y; Zheng H; Wang Z
J Genet Genomics; 2008 May; 35(5):313-6. PubMed ID: 18499076
[TBL] [Abstract][Full Text] [Related]
18. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
Lu D; Jimenez X; Witte L; Zhu Z
Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
[TBL] [Abstract][Full Text] [Related]
19. Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae.
Jørgensen ML; Friis NA; Just J; Madsen P; Petersen SV; Kristensen P
Microb Cell Fact; 2014 Jan; 13():9. PubMed ID: 24428896
[TBL] [Abstract][Full Text] [Related]
20. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
